Diabetes and the Heart

Diabetes and Glycemic Control -
Cardiovascular

	How to Obtain AMA PRA Category 1 Credit™ Watch the CME webcast. Take the CME posttest. Login to your account. Complete the registration / evaluation form. Print your personalized CME certificate. Technical Requirements

Release Date:   November 12, 2009
Expiration Date:  November 12, 2011

Estimated Time of Completion: 1 hour, 15 minutes

Description
The Diabetes and the Heart webcast series is composed of selected presentations from Diabetes and the Heart: A Clinical Summit on Critically Challenging Patients, a live symposium held August 6-7, 2009. The Summit was the inaugural educational activity of the Joslin Diabetes Center and Cleveland Clinic partnership.

With the increase in prevalence of the cardiometabolic syndrome and its comorbidities, the need to optimize preventive and therapeutic interventions is a major focus of most clinicians in primary care. Certainly, clinicians must recognize the signs and symptoms of the cardiometabolic syndrome and initiate early and effective preventive interventions. However, timely diagnosis and appropriate treatment are equally as important to reduce eventual morbidity and mortality.

Objectives
After completing this activity, the participant will be able to do the following:

1. Describe the epidemiology of heart failure and the impact of diabetes on the syndrome.
2. Discuss the pathophysiology of heart failure.
3. Identify the differences among peroxisome proliferator-activated receptor (PPAR) agonists with regard to their effects on lipids and cardiovascular risk.
4. Recognize the limitations of surrogate endpoints of glycemic control in trials of diabetic agents for the assessment of cardiovascular risk.

Target Audience
Primary care physicians, endocrinologists, cardiologists, nurse practitioners, physician assistants, nurses and other allied healthcare professionals will find this webcast valuable in their daily practice.

Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.

Faculty Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:

The following faculty has indicated that he has no relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:

Richard S. Beaser, MD

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:

Amylin Pharmaceuticals, Inc. and Lilly USA, LLC
Athena Diagnostics, Inc.
Daiichi Sankyo, Inc.
Merck & Co., Inc.
St. Jude Medical

This CME activity was produced by
the Cleveland Clinic Endocrinology and Metabolism Institute,
the Center for Continuing Education, and the Joslin Diabetes Center.

CME Disclaimer